Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
Crossref DOI link: https://doi.org/10.1007/s40273-015-0348-x
Published Online: 2016-02-16
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Druais, Sylvain
Doutriaux, Agathe
Cognet, Magali
Godet, Annabelle
Lançon, Christophe
Levy, Pierre
Samalin, Ludovic
Guillon, Pascal
License valid from 2016-02-16